- Home
- BNR vs ICMB Comparison
BNR vs ICMB Comparison
Compare BNR & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- ICMB
- Stock Information
- Founded
- BNR 2014
- ICMB 2012
- Country
- BNR China
- ICMB United States
- Employees
- BNR N/A
- ICMB N/A
- Industry
- BNR Medical Specialities
- ICMB Finance: Consumer Services
- Sector
- BNR Health Care
- ICMB Finance
- Exchange
- BNR Nasdaq
- ICMB Nasdaq
- Market Cap
- BNR 38.3M
- ICMB 40.6M
- IPO Year
- BNR 2020
- ICMB N/A
- Fundamental
- Price
- BNR $6.79
- ICMB $2.72
- Analyst Decision
- BNR
- ICMB
- Analyst Count
- BNR 0
- ICMB 0
- Target Price
- BNR N/A
- ICMB N/A
- AVG Volume (30 Days)
- BNR 58.0K
- ICMB 25.3K
- Earning Date
- BNR 08-21-2025
- ICMB 09-24-2025
- Dividend Yield
- BNR N/A
- ICMB 17.45%
- EPS Growth
- BNR N/A
- ICMB N/A
- EPS
- BNR N/A
- ICMB 0.82
- Revenue
- BNR $72,112,038.00
- ICMB $20,996,189.00
- Revenue This Year
- BNR $136.32
- ICMB N/A
- Revenue Next Year
- BNR N/A
- ICMB N/A
- P/E Ratio
- BNR N/A
- ICMB $3.34
- Revenue Growth
- BNR 0.53
- ICMB N/A
- 52 Week Low
- BNR $2.18
- ICMB $2.46
- 52 Week High
- BNR $9.48
- ICMB $3.47
- Technical
- Relative Strength Index (RSI)
- BNR 58.58
- ICMB 36.91
- Support Level
- BNR $6.03
- ICMB $2.52
- Resistance Level
- BNR $7.80
- ICMB $2.78
- Average True Range (ATR)
- BNR 1.00
- ICMB 0.08
- MACD
- BNR -0.08
- ICMB -0.02
- Stochastic Oscillator
- BNR 32.51
- ICMB 47.37
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.